Dermatology
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 28.
[Maffucci syndrome and extensive verrucous epidermal nevi in the same leg.]
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
We report a case of Maffucci syndrome associated with epidermal verrucous nevus. CASE REPORT: A 33-year-old woman, with no previous history of note, had presented multiple episodes of vascular tumefaction of the toes and verrucous lesions of the right lower limb since childhood. Clinical examination revealed multiple pain-free and round haemangiomas on the toes; some were hard and evocative of chondromas while others were soft and suggested angiomas. In addition, there was an epidermal verrucous nevus of the right lower limb. Skeletal examination revealed multiple phalangeal enchondromas. A diagnosis of Maffucci syndrome a...
Source: Annales de Dermatologie et de Cenereologie - September 30, 2009 Category: Dermatology Authors: Khoudri I, Chraïbi R, Khatibi B, El Meknassi I, Senouci K, Hassam B Tags: Ann Dermatol Venereol Source Type: journals
[Factors associated with delayed diagnosis of bullous pemphigoid.]Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CONCLUSION: Karnofsky score is the only parameter that appears to be associated with TD, with patients with worse scores having a shorter TD, probably due to better medical follow-up. Improved knowledge among general practitioners concerning the initial signs of the disease should shorten TD and accelerate the institution of appropriate therapy.
PMID: 19801252 [PubMed - in process]
Source: Annales de Dermatologie et de Cenereologie - September 30, 2009 Category: Dermatology Authors: Ingen-Housz-Oro S, Roujeau JC, Ferranti V, Le Roux-Villet C, Joly P Tags: Ann Dermatol Venereol Source Type: journals
[Desmoplastic Spitz nevus: A histopathological review and comparison with desmoplastic melanoma.]Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CONCLUSION: The combination of architectural and cytological features was useful in differentiating desmoplastic Spitz nevus from desmoplastic melanoma. A complete excision biopsy is mandatory in such tumors as the architectural criteria are necessary for a correct diagnosis.
PMID: 19801251 [PubMed - in process]
Source: Annales de Dermatologie et de Cenereologie - September 30, 2009 Category: Dermatology Authors: Nojavan H, Cribier B, Mehregan DR Tags: Ann Dermatol Venereol Source Type: journals
[Pandalao and skin whitening in Mayotte.]Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DISCUSSION: Although illegal, the trade in skin whitening products continues to grow because it is profitable and takes full advantage of the success of ethnic cosmetics. In Mayotte, as in metropolitan France and Africa, the existence of SW is acknowledged but is still taboo. However, a number of specific characteristics are seen in Mayotte: SW is rarely performed on the whole body, salicylic acid is added to a topical corticosteroid, and the traditional Mahoran mask, the "mzindzano", is still worn for photoprotection.
PMID: 19801250 [PubMed - in process]
Source: Annales de Dermatologie et de Cenereologie - September 30, 2009 Category: Dermatology Authors: Levang J, Eygonnet F, Humbert P Tags: Ann Dermatol Venereol Source Type: journals
[Universal pursuit of lightening?]Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PMID: 19801249 [PubMed - in process]
Source: Annales de Dermatologie et de Cenereologie - September 30, 2009 Category: Dermatology Authors: Petit A Tags: Ann Dermatol Venereol Source Type: journals
AAD Seal Program Off to a Slow StartEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Two years after the American Academy of Dermatology's Seal of Recognition program was launched, six products have been recognized for their sun protection benefits. In an interview, Dr. James M. Spencer, who oversees the program, said that he expected the list of recognized products “to be somewhat larger” by now. He acknowledged that part of the slow start may stem from controversy the program generated at the AAD's annual meeting in 2008, most notably by the late dermatopathologist A. Bernard Ackerman.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: DOUG BRUNK Tags: News Source Type: journals
Psoriasis Doesn't Up Hospitalization For Heart Disease: New study contradicts recent findings.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BUDAPEST — The last word on the relationship between psoriasis and cardiovascular disease may not be in, according to the results of a new study. Contrary to earlier studies, psoriasis was found to not be an independent risk factor for hospitalization for ischemic heart disease in a large Dutch study, Dr. Marlies Wakkee reported at the annual congress of the European Society for Dermatological Research.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: BRUCE JANCIN Tags: News Source Type: journals
Case of the MonthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A 5-year-old African American child presented with a 2-week history of swollen legs, abdominal pain, fever, fatigue, and blisters on her feet and toes. Her spleen was palpable, and she had an elevated white blood count and a low platelet count. What's your diagnosis? See Case of the Month, page 47.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Tags: News Source Type: journals
Triage of High-Risk Patients Is Key to Influenza StrategyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
While pandemic flu will probably be widespread throughout the country this fall and winter, the vast majority of people who contract pandemic influenza A (H1N1) will recover without testing and without any special treatment.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: MICHELE G. SULLIVAN Tags: News Source Type: journals
Vital Signs: Most Dermatologists are Office BasedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Tags: News Source Type: journals
H1N1 Vaccine Will Be Available Early This MonthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Vaccine against pandemic influenza A (H1N1) should start reaching providers early this month based on the planned opening of the orders process, a Centers for Disease Control and Prevention official said at a meeting of the National Vaccine Advisory Committee.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: MITCHEL L. ZOLER Tags: News Source Type: journals
UV Exposure May Be Tied to Dermatomyositis in WomenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The intensity of exposure to ambient ultraviolet radiation appears to determine the prevalence of dermatomyositis and an autoantibody specific to the disease in women, based on a recent study.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: JEFF EVANS Tags: News Source Type: journals
Fatal Skin Reactions Linked to HIV Drug ReportedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Warnings about severe skin reactions associated with the antiretroviral drug etravirine are being strengthened to include reports of hypersensitivity reactions and fatal cases of toxic epidermolysis necrolysis associated with the drug.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: ELIZABETH MECHCATIE Tags: News From the FDA Source Type: journals
Panel Backs Romidepsin as Second-Line CTCL TherapyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SILVER SPRING, MD. — The Food and Drug Administration's Oncologic Drugs Advisory Committee voted 10-0, with 1 abstention, that two single-arm trials of romidepsin show that the drug has a favorable risk-benefit profile as a second-line treatment for patients with cutaneous T-cell lymphoma.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: ELIZABETH MECHCATIE Tags: News From the FDA Source Type: journals
FDA Advisers Support HPV Vaccine for MalesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SILVER SPRING, MD. — In nearly unanimous votes, a Food and Drug Administration advisory panel agreed that data on Gardasil supported the efficacy and safety of the vaccine for use in preventing genital warts caused by human papillomavirus types 6 and 11 in boys and men aged 9-26 years.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: ELIZABETH MECHCATIE Tags: News From the FDA Source Type: journals
Second HPV Vaccine for Girls, Women Backed by PanelEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SILVER SPRING, MD. — The majority of a federal advisory panel agreed that the data on a recombinant bivalent human papillomavirus vaccine indicate that the vaccine is safe and effective in preventing cervical cancer and certain precancerous or dysplastic lesions caused by HPV types 16 and 18 in girls and women aged 10-25 years.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: ELIZABETH MECHCATIE Tags: News From the FDA Source Type: journals
5-Year Data Support Rituximab for PemphigusEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BUDAPEST — Rituximab for the treatment of severe pemphigus continued to demonstrate positive results in the 2-year extension of a landmark 3-year multicenter trial. After 5 years of follow-up, 19 of 22 rituximab-treated patients (86%) were in complete or near-complete remission, including 8 who were off all therapies, Dr. Pascal Joly reported at the annual congress of the European Society for Dermatological Research.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: BRUCE JANCIN Tags: News Source Type: journals
Professionalism LivesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DR. WORTMANN is professor of medicine at the Dartmouth-Hitchcock Medical Center, Lebanon, N.H. The medical drama “Marcus Welby, M.D.,” seen on television from September 1969 through July 1976, followed the older Dr. Welby as he drove around in his long sedan, caring for his patients in the hospital, in his office, at the nursing home, and even in their homes. (Those visits were called “house calls.”)
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: ROBERT L. WORTMANN Tags: Commentary Source Type: journals
The Exploding Squid and Other TalesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DR. ROCKOFF practices dermatology in Brookline, Mass. To respond to this column, e-mail Dr. Rockoff at sknews@elsevier.com. There was a comic when I was a kid called “The Strange World of Mr. Mum.” Each strip featured an impassive gent in a small fedora who looked on, mum, at the odd things that always seemed to be going on as he passed by, like two masked crooks robbing each other at the same time.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: ALAN ROCKOFF Tags: Under My Skin Source Type: journals
Is there a role for atopy patch testing?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DR. SPERGEL is an associate professor of pediatrics and director of the Food Allergy Center at the Children's Hospital of Philadelphia. Dr. Spergel disclosed that he has served as a speaker or consultant for GlaxoSmithKline, AstraZeneca, Schering-Plough, and Nutricia, and has received grant support from Ception and Novartis.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: JONATHAN M. SPERGEL, AMAL H. ASSA'AD Tags: Point/Counterpoint Source Type: journals
GlucosamineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DR. BAUMANN is director of cosmetic dermatology at the University of Miami. To respond to this column, or to suggest topics for future columns, write to Dr. Baumann at our editorial offices via e-mail at sknews@elsevier.com.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: LESLIE S. BAUMANN Tags: Cosmeceutical Critique Source Type: journals
Choosing the Right Filler Comes With ExperienceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BOSTON — Cosmetic dermatologists have the knowledge and training to choose the right fillers that will garner the best results, according to Dr. Mary Lupo. “Every FDA-approved filler, in my opinion, has an appropriate indication. You just need to know the relative strengths and weaknesses,” said Dr. Lupo, at the American Academy of Dermatology's Academy 2009 meeting.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: KERRI WACHTER Tags: Aesthetic Dermatology Source Type: journals
Island Pedicle Flap Provides Volume, Spares TissueEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PORTLAND, ORE. — Its ability to provide volume and spare tissue makes the island pedicle flap a valuable technique for deep facial defects. “When you can just about close a defect primarily and have concerns that doing so might cause unnecessary contour deformity or free margin retraction, an island pedicle flap taken from the standing cutaneous cone will rescue the repair and provide excellent cosmesis with minimal tissue loss,” Dr. Roberta Sengelmann said at the annual meeting of the Pacific Dermatologic Association.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: DOUG BRUNK Tags: Aesthetic Dermatology Source Type: journals
Hedgehog Pathway Inhibitor Helps Fight CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new drug that inhibits the hedgehog signaling pathway has shown “remarkable” antitumor activity against basal cell carcinoma and medulloblastoma, according to two reports. The hedgehog signaling pathway regulates cell growth and differentiation during early development but is inactive in healthy adults. However, it appears that mutations in components of the pathway can cause malignant growth in some cases of medulloblastoma, the most common brain cancer in children, and in several cancers in adults, notably basal cell carcinoma.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: MARY ANN MOON Tags: Cutaneous Oncology Source Type: journals
AEIOU May Help Make Merkel Cell DiagnosisEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PORTLAND, ORE. — Skin lesions are a hallmark of Merkel cell carcinoma, yet dermatologists often find themselves out of the loop in diagnosing patients with the disease, said Dr. Paul Nghiem.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: DOUG BRUNK Tags: Cutaneous Oncology Source Type: journals
Unexplained Changes to The Nail Warrant BiopsyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BOSTON — The threshold for biopsying unexplained nail dystrophy or discoloration should be low, according to Dr. Phoebe Rich. Although the majority of nail unit lesions are benign, “malignancies are not as obvious to spot clinically as you would think,” and a missed or delayed diagnosis can be life threatening, Dr. Rich said at the American Academy of Dermatology's Academy 2009 meeting.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: DIANA MAHONEY Tags: Cutaneous Oncology Source Type: journals
Emollient Tx From Birth May Prevent EczemaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PORTLAND, ORE. — Beginning emollient therapy at birth is a safe and feasible approach to prevent eczema, results from a small pilot study suggest. “Decades of research on allergen avoidance has not led to any successful strategy so far,” Dr. Eric Simpson said at the annual meeting of the Pacific Dermatologic Association.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: DOUG BRUNK Tags: Pediatric Dermatology Source Type: journals
Collaboration Key to Treating With PropranololEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BOSTON — Establishing a treatment protocol and seeking the collaboration of cardiologists who treat children may limit the potential for serious complications associated with the off-label use of propranolol for the treatment of severe infantile hemangiomas, according to Dr. Elaine C. Siegfried.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: DIANA MAHONEY Tags: Pediatric Dermatology Source Type: journals
Counting Hemangiomas Can Help Determine RiskEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Counting hemangiomas is one way to identify higher risk when managing infantile hemangiomas, which are tremendously heterogeneous, according to Dr. Ilona J. Frieden. For example, having more than five infantile hemangiomas increases the risk of having liver hemangiomas, she explained at a women's and pediatric dermatology seminar sponsored by Skin Disease Education Foundation (SDEF).
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: SHERRY BOSCHERT Tags: Pediatric Dermatology Source Type: journals
Diagnostic Test for Kawasaki May Be Near RealityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VAIL, COLO. — By far the greatest need in Kawasaki disease is for a diagnostic laboratory test—and recent developments suggest that gene expression testing may be the answer. “I don't think we're going to have a diagnostic test tomorrow, but with refinement I'm hopeful that gene expression profiling might be the basis of a diagnostic test,” Dr. Marsha Anderson said at a conference on pediatric infectious diseases sponsored by the Children's Hospital, Denver.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: BRUCE JANCIN Tags: Pediatric Dermatology Source Type: journals
Anti-TNF Agent May Be Next Kawasaki TherapyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VAIL, COLO. — The next frontier in Kawasaki disease therapy will involve determining the role of anti–tumor necrosis factor–alpha therapy. There are sound theoretical reasons why an anti-TNF agent such as infliximab should be beneficial in patients with Kawasaki disease. Anecdotal reports have suggested that this is indeed the case when infliximab is given to patients with persistent fever after a first dose of intravenous immunoglobulin (IVIG).
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: BRUCE JANCIN Tags: Pediatric Dermatology Source Type: journals
Consider Kawasaki Disease in Patients Presenting With ShockEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VAIL, Colo. — Patients with severe Kawasaki disease can present in shock—and that's something not widely appreciated in emergency departments and ICUs. This was the thrust of two recent studies of severe Kawasaki disease conducted in Denver and San Diego.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: BRUCE JANCIN Tags: Pediatric Dermatology Source Type: journals
Epidermolysis Bullosa Commands Aggressive TxEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PHILADELPHIA — When it comes to the management of epidermolysis bullosa, patient preference for bathing and dressings is important, follow-up is key to the treatment of associated anemia, and lesions suspicious for squamous cell carcinoma should undergo early biopsy and be treated aggressively, according to Dr. Dedee F. Murrell, an expert in the care of patients with this painful condition.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: KERRI WACHTER Tags: Pediatric Dermatology Source Type: journals
Consider DRESS in Kids With Drug Rash, FeverEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VAIL, COLO. — Drug rash with eosinophilia and systemic symptoms, or DRESS, needs to be included in the differential diagnosis when a patient presents with fever and a rash 1-8 weeks after starting a drug, according to Heather R. Heizer.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: BRUCE JANCIN Tags: Infectious Diseases Source Type: journals
Neonatal MRSA Is Often Community AcquiredEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MONTREAL — Community-acquired strains are the most common source of methicillin-resistant Staphylococcus aureus colonization and infection in babies in the neonatal intensive care unit, even though they have never left the hospital, researchers found.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: KATE JOHNSON Tags: Infectious Diseases Source Type: journals
Zoster Risk Sharply Reduced After Varicella VaccinationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VAIL, Colo. — The risk of herpes zoster in children under age 10 years who've been vaccinated against varicella was 4- to 12-fold less than in those with naturally acquired varicella in a large population-based study.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: BRUCE JANCIN Tags: Infectious Diseases Source Type: journals
Circumcision and MRSAEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DR. PELTON is chief of pediatric infectious disease and coordinator for the maternal-child HIV program at Boston Medical Center. To respond to this column, e-mail Dr. Pelton at sknews@elsevier.com.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: STEPHEN I. PELTON Tags: Expert Opinion Source Type: journals
HPV Vaccine Marketing Practices QuestionedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Women at the highest risk for human papillomavirus infection were among the least likely to get the message that there is a vaccine that can protect them, editorialists said in a special communication published in JAMA.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: DIANA MAHONEY Tags: Infectious Diseases Source Type: journals
Chikungunya Fever: Could an Outbreak Happen Here?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VAIL, COLO. — Chikungunya fever is a tropical disease few American physicians are familiar with—but that could change quite suddenly, as physicians in temperate northern Italy discovered.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: BRUCE JANCIN Tags: Infectious Diseases Source Type: journals
Hemostatic Agents Can Help Control BleedingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PORTLAND, ORE. — As the chief of dermatologic surgery at the University of Washington, Seattle, Dr. Daniel Berg likes to have a handful of nontraditional topical hemostatic agents handy.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: DOUG BRUNK Tags: Dermatologic Surgery Source Type: journals
Demand Soars for Postbariatric Cosmetic Surgery: Body contouring procedures can help produce an immeasurable impact on a patient's self-perception.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The proliferation of bariatric surgery procedures performed each year in the United States has led to a burgeoning demand for body contouring. Prior to 2000, it was rare for patients who experienced massive weight loss to seek help from plastic surgeons; in fact, this patient population was almost nonexistent, according to Dr. Al Aly, a board-certified plastic surgeon who practices in Iowa City.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: DOUG BRUNK Tags: Dermatologic Surgery Source Type: journals
Data Watch: Top Five Cosmetic Surgical Procedures Down in 2008Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Tags: Dermatologic Surgery Source Type: journals
Policy & Practice: Can't get enough Policy & Practice? Check out our new podcast each Monday. egmnblog.wordpress.comEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The FDA has warned Galderma Laboratories that its promotions of Tri-Luma “recommend or suggest uses … that have not been approved by FDA.” The Tri-Luma promotions also omit and minimize risk information, said the FDA's Division of Drug Marketing, Advertising, and Communications in its 10-page letter to the company. The combination of fluocinolone acetonide, hydroquinone, and tretinoin is approved for short-term treatment of moderate to severe melasma. The company has been promoting Tri-Luma for use with glycolic acid peels, the agency said, calling it “concerning, from a safety perspective.” The materials also su...
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: Alicia Ault Tags: Practice Trends Source Type: journals
An Ironman Competes to Give BackEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dr. James Barron never took physical fitness seriously until age 30, when he served as the physician for a Marine battalion, but he'd always been intrigued by watching Ironman competitions on television—grueling events that consist of a 2.4-mile swim, a 112-mile bike ride, and a 26-mile run.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: Doug Brunk Tags: The Rest of Your Life Source Type: journals
Making Learning FunEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DR. EASTERN practices dermatology and dermatologic surgery in Belleville, N.J. To respond to this column, or to get information on RxDerm-L membership, e-mail Dr. Eastern at sknews@elsevier.com.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: JOSEPH S. EASTERN Tags: Managing Your Dermatology Practice Source Type: journals
Keep Employees, Patients Happy to Ensure a Healthy PracticeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Hire great employees. Train and treat them well. Give a lot of positive reinforcement. Those were three pieces of advice offered by Dr. Suzanne L. Kilmer at a cosmetic dermatology seminar sponsored by Skin Disease Education Foundation (SDEF).
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: MIRIAM E. TUCKER Tags: Practice Trends Source Type: journals
Group Practice Demo Achieved Modest SavingsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CHICAGO — The Medicare Physician Group Practice Demonstration achieved modest cost savings and quality enhancements in the project's first 2 performance years, researchers reported at the annual research meeting of AcademyHealth. Data released in August reinforce that finding.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: SUSAN BIRK Tags: Practice Trends Source Type: journals
Direct-to-Consumer Genetic Tests Seen as ProblematicEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WASHINGTON — Few physicians feel prepared to interpret findings from direct-to-consumer genetic tests and incorporate the results into clinical practice, according to speakers at a National Academy of Sciences workshop on DTC genetic testing.
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: JEFF EVANS Tags: Practice Trends Source Type: journals
ProductsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Hylatopic has been approved by the Food and Drug Administration for treating atopic, radiation, and allergic contact dermatitis. The emollient foam is a nonsteroidal product available by prescription. The foam is designed to hydrate the top layer of skin and provide a semipermeable protective barrier to reduce irritation and excessive moisture loss. The product is alcohol free, and absorbs quickly without leaving a residue. The foam is formulated to spread easily over large areas of the body to help relieve burning and itching skin. The product does not contain sunscreen, and it should not be used before periods of extende...
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Source Type: journals
Case of the MonthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
This case of leukemia cutis due to aggressive natural killer cell leukemia is uncommon, and perhaps even unique. Leukemia cutis seldom occurs in children, and is seen in only 6%-9% of children with leukemia. There have been only a few reports of aggressive natural killer (NK) cell leukemia presenting in childhood. This may be the first case of bullous leukemia cutis and aggressive NK cell leukemia in a child, according to Dr. Harper N. Price. The girl also tested negative for Epstein-Barr virus (EBV), which commonly is present in aggressive NK cell leukemia. She appears to be the first child to be reported with EBV-negati...
Source: Skin and Allergy News - September 30, 2009 Category: Dermatology Authors: Sherry Boschert Source Type: journals
